Examples of 'significant pharmacokinetic' in a sentence
Meaning of "significant pharmacokinetic"
significant pharmacokinetic - This phrase pertains to the measurable effects, changes, or processes that a drug or substance undergoes within the body over a specific period. It indicates the noteworthy or meaningful impact of a drug on its absorption, distribution, metabolism, and excretion within a biological system, influencing its overall pharmacological behavior
How to use "significant pharmacokinetic" in a sentence
Basic
Advanced
significant pharmacokinetic
No clinically significant pharmacokinetic interactions were found in each case.
When zolpidem was administrated with ranitidine or cimetidine, no significant pharmacokinetic interactions were observed.
No significant pharmacokinetic interactions are expected between mirtazapine and other.
With the simultaneous use of fimasartan and amlodipine, significant pharmacokinetic drug interaction was not observed.
No clinically significant pharmacokinetic interaction was detected in any of the cases.
When Zontivity was co-administered with prasugrel, no clinically significant pharmacokinetic interaction was demonstrated.
No significant pharmacokinetic differences have been observed between males and females.
Efavirenz, No clinically significant pharmacokinetic interaction.
No significant pharmacokinetic changes have been observed when tacrolimus is given intravenously.
No clinically significant pharmacokinetic interaction.
No significant pharmacokinetic difference was observed between the Caucasian and the Hispanic postmenopausal women.
No clinically significant pharmacokinetic change.
No significant pharmacokinetic alteration has been observed in these patients see section 5.2.
No clinically significant pharmacokinetic interaction The geometric mean Cmin for.
Significant pharmacokinetic data obtained in rats at a 15 mg / kg dose were as follows,.
See also
Dexamethasone has no clinically significant pharmacokinetic interaction with thalidomide, lenalidomide, pomalidomide, bortezomib, vincristine or doxorubicin.
There are no significant pharmacokinetic differences between intramuscular and subcutaneous administration of Fertavid.
No clinically significant pharmacokinetic interaction was seen when fenofibrate was coadministered with pravastatin.
There are no significant pharmacokinetic differences between intramuscular and subcutaneous administration of Puregon.
Gender No significant pharmacokinetic differences have been observed between men and women.
No clinically significant pharmacokinetic interactions when tenofovir disoproxil was co-administered with entecavir.
Thus, a clinically significant pharmacokinetic interaction between olanzapine and valproate is unlikely.
No clinically significant pharmacokinetic drug-drug interactions were observed in studies with digoxin or warfarin.
No clinically significant pharmacokinetic drug-drug interactions were observed in studies with digoxin and warfarin.
Therefore, clinically significant pharmacokinetic drug-drug interactions in metabolism related to these isoenzymes are unlikely.
No clinically significant pharmacokinetic drug-drug interactions were observed in studies with methotrexate, digoxin or warfarin.
No clinically significant pharmacokinetic interaction was observed between sirolimus and 0.3 mg norgestrel / 0.03 mg ethinyl estradiol.
No clinically significant pharmacokinetic interaction The geometric mean Cmin for indinavir ( 0.33 mg / l ) when given with.
You'll also be interested in:
Examples of using Pharmacokinetic
Show more
The pharmacokinetic genes inform the dosage
There are no marked changes in the pharmacokinetic parameters
Pharmacokinetic interaction studies have not been conducted
Examples of using Significant
Show more
Significant resources had been allocated for education
You have done significant damage to your heart
Significant direct and indirect employment created
